甲胺蝶呤市場規模按適應症（牛皮癬、類風濕性關節炎、癌症）、模式（內部、合約製造）、合成類型（化學原料藥、高效原料藥(HPAPI)） - 全球預測，2023-2032年

在蓬勃發展的製藥產業的推動下，全球甲胺蝶呤市場預計到 2032 年CAGR將超過 5%。隨著醫療保健優先事項的發展，對有效治療方案的需求不斷成長，凸顯了產品治療應用範圍的擴大。

慢性病發病率不斷上升是另一個主要成長動力。根據世界衛生組織 2023 年的報告，非傳染性疾病 (NCD) 每年奪走 4,100 萬人的生命，佔全球死亡人數的 74%。值得注意的是，有 1700 萬人在 70 歲之前死於非傳染性疾病，其中 86% 的過早死亡發生在低收入和中等收入國家。甲氨蝶呤是一種成熟的緩解疾病抗風濕藥物 (DMARD)，由於其在治療類風濕關節炎和牛皮癬等自體免疫疾病方面的功效，其採用率越來越高。此外，它在癌症治療中的作用，特別是在白血病和乳癌中的作用，對市場成長做出了重大貢獻。

整個甲氨蝶呤市場根據適應症、模式、合成類型和地區進行分類。

由於甲胺蝶呤在白血病、乳癌和某些類型淋巴瘤化療方案中的應用，癌症領域預計在 2023 年至 2032 年期間取得顯著進展。對甲氨蝶呤在多種癌症治療中的潛力的不斷探索強調了其作為腫瘤學領域基石治療劑的重要性。

預計合約製造部門在預測期內將出現強勁成長。製藥公司擴大利用合約製造組織 (CMO) 來簡化生產流程、提高效率並確保符合監管標準。與 CMO 的合作促進了甲氨蝶呤的無縫生產和分銷，推動創新並確保全球患者更容易獲得。

在該地區人口迅速成長和醫療基礎設施不斷發展的推動下，亞太地區甲氨蝶呤市場預計到 2032 年將快速成長。慢性病盛行率不斷上升，推動了對有效治療方案的需求。中國和印度等國家的製藥業不斷擴大，在甲胺蝶呤的生產和消費中發揮至關重要的作用，從而塑造了區域市場動態。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：甲胺蝶呤產業洞察

• COVID-19 影響分析
• 產業生態系統分析
• 技術景觀
• 監管環境
• 產業影響力
  • 成長動力
    • 慢性病盛行率上升
    • 監管機構核准的藥品數量不斷增加
    • 使用甲氨蝶呤藥物的持續研究和開發
    • 不斷成長的技術進步和對個人化醫療的需求
  • 產業陷阱與挑戰
    • 不良反應和安全問題
    • 有限的報銷和承保政策
• 成長潛力分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
  • Novartis AG (Sandoz)
  • Merck & Co., Inc
  • Sun Pharmaceutical Industries Ltd
• 競爭定位矩陣
• 市佔率/排名分析
  • 全球的
  • 北美洲
  • 歐洲
  • 亞太地區
• 生產能力
• 排名前 20 名的最終消費者名單以及聯絡資訊/電子郵件 ID

第 5 章：甲胺蝶呤市場估計與預測：按適應症

• 主要動向：依指示
• 牛皮癬
• 類風濕關節炎
• 癌症
• 其他

第 6 章：甲胺蝶呤市場估計與預測：按模式

• 主要動向：按模式
• 內部
• 合約起草（名詞

第 7 章：甲胺蝶呤市場估計與預測：按合成類型

• 主要動向：依合成型
• 化學原料藥
• 高效能 API (HPAPI)

第 8 章：甲胺蝶呤市場估計與預測：按地區

• 主要動向：按地區
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 馬來西亞
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國

第 9 章：公司簡介

• Teva Pharmaceutical Industries Ltd
• Sun Pharmaceutical Industries Ltd
• Aurobindo Pharma Ltd
• Lonza Group AG
• Merck & Co., Inc
• Fermion (Orion Corporation)
• Avra Laboratories Pvt Ltd
• Rochem International Inc
• LGM Pharm
• Sandoz AG (Novartis AG)

The global methotrexate market is poised to record over 5% CAGR through 2032, propelled by the booming pharmaceutical sector. As healthcare priorities evolve, the demand for effective treatment options grows, highlighting the broadening spectrum of product's therapeutic applications.

The escalating incidence of chronic diseases is another main growth driver. As per a report by WHO in 2023, noncommunicable diseases (NCDs) claim the lives of 41 million individuals annually, representing 74% of global fatalities. Notably, 17 million people succumb to NCDs before the age of 70 years, with a substantial 86% of these premature deaths occurring in low- and middle-income countries. Methotrexate, a well-established disease-modifying antirheumatic drug (DMARD), has witnessed increased adoption due to its efficacy in managing autoimmune disorders such as rheumatoid arthritis and psoriasis. Furthermore, its role in cancer treatment, particularly in leukaemia and breast cancer, contributes significantly to the market growth.

The overall methotrexate market is classified based on indication, mode, synthesis type, and region.

The cancer segment is poised to witness significant gains during 2023-2032 driven by methotrexate's utility in chemotherapy protocols for leukaemia, breast cancer, and certain types of lymphomas. The continuous exploration of Methotrexate's potential in diverse cancer treatments underscores its importance as a cornerstone therapeutic agent in the oncology field.

The contract manufacturing segment is anticipated to witness robust growth during the forecast period. The pharmaceutical companies increasingly leverage contract manufacturing organizations (CMOs) to streamline production processes, enhance efficiency, and ensure compliance with regulatory standards. Collaborations with CMOs facilitate the seamless production and distribution of methotrexate, driving innovation and ensuring broader accessibility for patients globally.

Asia Pacific methotrexate market is expected to register swift growth through 2032 driven by the region's burgeoning population and evolving healthcare infrastructure. There is an increased prevalence of chronic diseases, driving the demand for effective treatment options. Countries like China and India, with their expanding pharmaceutical sectors, play a crucial role in the production and consumption of methotrexate, thereby shaping the regional market dynamics.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast calculations
• 1.4 Data Sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global methotrexate market 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends
• 2.3 Indication trends
• 2.4 Mode trends
• 2.5 Synthesis type trends

Chapter 3 Methotrexate Industry Insights

• 3.1 COVID- 19 impact analysis
• 3.2 Industry ecosystem analysis
• 3.3 Technology landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Rising prevalence of chronic diseases
    • 3.5.1.2 Growing number of drug approvals by regulatory bodies
    • 3.5.1.3 Ongoing research and development using methotrexate drugs
    • 3.5.1.4 Rising technological advancements and demand for personalized medicine
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Adverse effects and safety concerns
    • 3.5.2.2 Limited reimbursement and coverage policies
• 3.6 Growth potential analysis
  • 3.6.1 By indication
  • 3.6.2 By mode
  • 3.6.3 By synthesis type
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Novartis AG (Sandoz)
  • 4.1.2 Merck & Co., Inc
  • 4.1.3 Sun Pharmaceutical Industries Ltd
• 4.2 Competitive positioning matrix, 2022
• 4.3 Market share/ rank analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Production capacity
• 4.5 List of top 20 end consumers with contact details/email id

Chapter 5 Methotrexate Market Estimates and Forecast, By Indication (Revenue)

• 5.1 Key trends, by indication
• 5.2 Psoriasis
• 5.3 Rheumatoid arthritis
• 5.4 Cancer
• 5.5 Others

Chapter 6 Methotrexate Market Estimates and Forecast, By Mode (Revenue)

• 6.1 Key trends, by mode
• 6.2 In-house
• 6.3 Contract manufacturing

Chapter 7 Methotrexate Market Estimates and Forecast, By Synthesis Type (Revenue)

• 7.1 Key trends, by synthesis type
• 7.2 Chemical based API
• 7.3 Highly potent API (HPAPI)

Chapter 8 Methotrexate Market Estimates and Forecast, By Region (Revenue & Volume)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Malaysia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Teva Pharmaceutical Industries Ltd
• 9.2 Sun Pharmaceutical Industries Ltd
• 9.3 Aurobindo Pharma Ltd
• 9.4 Lonza Group AG
• 9.5 Merck & Co., Inc
• 9.6 Fermion (Orion Corporation)
• 9.7 Avra Laboratories Pvt Ltd
• 9.8 Rochem International Inc
• 9.9 LGM Pharm
• 9.10 Sandoz AG (Novartis AG)

Data Tables

• TABLE 1. Global methotrexate market size, 2018 - 2024 (USD Million)
• TABLE 2. Global methotrexate market size, 2025 - 2032 (USD Million)
• TABLE 3. Global methotrexate market size, by region, 2018 - 2024 (USD Million)
• TABLE 4. Global methotrexate market size, by region, 2025 - 2032 (USD Million)
• TABLE 5. Global methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 6. Global methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 7. Global methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 8. Global methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 9. Global methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 10. Global methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 11. Comprehensive study of API supply chain of the U.S. and Europe
• TABLE 12. Basic differences in API registration in the U.S. AND EU
• TABLE 13. Innovation & sustainability in methotrexate
• TABLE 14. Methotrexate selling price per kg, by region, 2022
• TABLE 15. Competitive positioning matrix: Classification criteria
• TABLE 16. Production capacity, 2022
• TABLE 17. List of top 20 end consumers with contact details/email id
• TABLE 18. Psoriasis market size, 2018 - 2024 (USD Million)
• TABLE 19. Psoriasis market size, 2025 - 2032 (USD Million)
• TABLE 20. Rheumatoid arthritis market size, 2018 - 2024 (USD Million)
• TABLE 21. Rheumatoid arthritis market size, 2025 - 2032 (USD Million)
• TABLE 22. Cancer market size, 2018 - 2024 (USD Million)
• TABLE 23. Cancer market size, 2025 - 2032 (USD Million)
• TABLE 24. Other indications market size, 2018 - 2024 (USD Million)
• TABLE 25. Other indications market size, 2025 - 2032 (USD Million)
• TABLE 26. In-house manufacturing market size, 2018 - 2024 (USD Million)
• TABLE 27. In-house manufacturing market size, 2025 - 2032 (USD Million)
• TABLE 28. Contract manufacturing market size, 2018 - 2024 (USD Million)
• TABLE 29. Contract manufacturing market size, 2025 - 2032 (USD Million)
• TABLE 30. Chemical based API market size, 2018 - 2024 (USD Million)
• TABLE 31. Chemical based API market size, 2025 - 2032 (USD Million)
• TABLE 32. Highly potent API (HPAPI) market size, 2018 - 2024 (USD Million)
• TABLE 33. Highly potent API (HPAPI) market size, 2025 - 2032 (USD Million)
• TABLE 34. North America methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 35. North America methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 36. North America methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 37. North America methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 38. North America methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 39. North America methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 40. North America methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 41. North America methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 42. U.S. methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 43. U.S. methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 44. U.S. methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 45. U.S. methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 46. U.S. methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 47. U.S. methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 48. Canada methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 49. Canada methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 50. Canada methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 51. Canada methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 52. Canada methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 53. Canada methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 54. Europe methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 55. Europe methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 56. Europe methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 57. Europe methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 58. Europe methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 59. Europe methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 60. Europe methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 61. Europe methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 62. Germany methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 63. Germany methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 64. Germany methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 65. Germany methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 66. Germany methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 67. Germany methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 68. UK methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 69. UK methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 70. UK methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 71. UK methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 72. UK methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 73. UK methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 74. France methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 75. France methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 76. France methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 77. France methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 78. France methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 79. France methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 80. Italy methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 81. Italy methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 82. Italy methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 83. Italy methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 84. Italy methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 85. Italy methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 86. Spain methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 87. Spain methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 88. Spain methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 89. Spain methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 90. Spain methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 91. Spain methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 92. Russia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 93. Russia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 94. Russia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 95. Russia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 96. Russia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 97. Russia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 98. Rest of Europe methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 99. Rest of Europe methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 100. Rest of Europe methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 101. Rest of Europe methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 102. Rest of Europe methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 103. Rest of Europe methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 104. Asia Pacific methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 105. Asia Pacific methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 106. Asia Pacific methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 107. Asia Pacific methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 108. Asia Pacific methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 109. Asia Pacific methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 110. Asia Pacific methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 111. Asia Pacific methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 112. China methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 113. China methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 114. China methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 115. China methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 116. China methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 117. China methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 118. Japan methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 119. Japan methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 120. Japan methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 121. Japan methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 122. Japan methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 123. Japan methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 124. India methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 125. India methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 126. India methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 127. India methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 128. India methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 129. India methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 130. South Korea methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 131. South Korea methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 132. South Korea methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 133. South Korea methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 134. South Korea methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 135. South Korea methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 136. Malaysia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 137. Malaysia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 138. Malaysia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 139. Malaysia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 140. Malaysia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 141. Malaysia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 142. Australia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 143. Australia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 144. Australia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 145. Australia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 146. Australia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 147. Australia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 148. Rest of Asia Pacific methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 149. Rest of Asia Pacific methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 150. Rest of Asia Pacific methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 151. Rest of Asia Pacific methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 152. Rest of Asia Pacific methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 153. Rest of Asia Pacific methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 154. Latin America methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 155. Latin America methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 156. Latin America methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 157. Latin America methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 158. Latin America methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 159. Latin America methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 160. Latin America methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 161. Latin America methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 162. Brazil methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 163. Brazil methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 164. Brazil methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 165. Brazil methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 166. Brazil methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 167. Brazil methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 168. Mexico methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 169. Mexico methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 170. Mexico methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 171. Mexico methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 172. Mexico methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 173. Mexico methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 174. Rest of Latin America methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 175. Rest of Latin America methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 176. Rest of Latin America methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 177. Rest of Latin America methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 178. Rest of Latin America methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 179. Rest of Latin America methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 180. Middle East & Africa methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 181. Middle East & Africa methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 182. Middle East & Africa methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 183. Middle East & Africa methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 184. Middle East & Africa methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 185. Middle East & Africa methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 186. Middle East & Africa methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 187. Middle East & Africa methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 188. South Africa methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 189. South Africa methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 190. South Africa methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 191. South Africa methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 192. South Africa methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 193. South Africa methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 194. Saudi Arabia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 195. Saudi Arabia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 196. Saudi Arabia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 197. Saudi Arabia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 198. Saudi Arabia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 199. Saudi Arabia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 200. UAE methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 201. UAE methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 202. UAE methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 203. UAE methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 204. UAE methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 205. UAE methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 206. Rest of MEA methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 207. Rest of MEA methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 208. Rest of MEA methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 209. Rest of MEA methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 210. Rest of MEA methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 211. Rest of MEA methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)

Charts & Figures

• FIG. 1 Research design
• FIG. 2 Data collection techniques
• FIG. 3 Primary research process
• FIG. 4 Market sizing approach
• FIG. 5 Forecasting model
• FIG. 6 Global industry snapshot
• FIG. 7 Industry ecosystem analysis
• FIG. 8 Growth potential analysis, by indication
• FIG. 9 Growth potential analysis, by mode
• FIG. 10 Growth potential analysis, by synthesis type
• FIG. 11 Porter's analysis
• FIG. 12 PESTEL analysis
• FIG. 13 Competitive analysis of major market players, 2022
• FIG. 14 Competitive positioning matrix, 2022
• FIG. 15 Strategic outlook matrix, 2022
• FIG. 16 Global company share analysis, 2022
• FIG. 17 North America company share analysis, 2022
• FIG. 18 Europe company share analysis, 2022
• FIG. 19 Asia Pacific company share analysis, 2022